Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
On this on-demand webinar collection, Dr. Igor Makhlin discusses customized remedy choices for sufferers with estrogen receptor–optimistic, HER2-negative metastatic breast most cancers, together...
Gastrointestinal stromal tumors (GIST) are usually recognized by way of a mix of symptom consciousness and specialised checks, based on Dr. Weijing Solar,...
Including SCIB1 or iSCIB1+ to straightforward therapies helped extra sufferers with superior melanoma reply and stay longer with out additional uncomfortable side effects:...
